Computational Biology Market Analysis By Application (Cellular & Biological Simulation, Pharmacogenomics, Drug Discovery, Drug Development, Lead Optimization, Lead Discovery, Pharmacokinetics, Pharmacodynamics, Disease Modeling, Clinical Trials), By Service (In-house, Contract), By End User (Academics, Industry, Commercial) And Segment Forecasts To 2020

Published: Jul, 2014 | Pages: 103 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global market for computational biology is expected to reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%. Steady increase in the usage & application of computational biology for bioinformatics R&D programs designed for sequencing genomes to better understand biological systems and increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug discovery studies are expected to drive computational biology demand over the next six years.

Computational genomics for cellular and biological simulation applications dominated the market in 2013, accounting for over 47% of global revenue. Key factors driving demand for these applications include the growth of drug designing, disease modeling and personalized medicine applications and the growing usage of computational biology for functional and structural genomics, epigenomics and metagenomics for the analysis of protein transcription, protein-protein interactions, gene sequencing and expression and 3-dimensional protein structure analysis.

Further key findings from the study suggest:

North America was the largest regional market, accounting for 58.0% of the global revenue in 2013. Its large share is majorly attributed to the growing research investments and initiatives for development of drug discovery, disease modeling technologies and innovations in biological computation methods. It is expected that Asia Pacific will witness the fastest growth in the market, at an estimated CAGR of 28.0% owing to the increasing expenditure in clinical studies for pharmacokinetics and pharmacogenomics.
The application of computational biology in proteomics for cellular simulation is expected to grow at the fastest CAGR of over 22% owing to the shift in sequencing studies towards further analysis of the nature of various biological proteins as a part of development of personalized medicine.
Drug discovery and disease modelling applications dominated the market, accounting for 58.0% of global revenue in 2013. This large share is attributed by the extensive drug development pipelines present for a number of global branded and generic drug manufacturing firms such as Sanofi, Novo Nordisk and Eli Lilly.
Computational Biology databases dominated the tools segment and accounted for 44.5% of the market revenue in 2013, owing to extensive genomic database usage for warehousing and data mining of biological and sequential data generated from genomic and proteomic studies. Consequentially, the software and services for the analysis of biological data is expected to witness the fastest CAGR of over 21.0%.
Key players of this market include Schrodinger, Accelrys, Certara, Entelos, Simulation Plus and others.
For the purpose of this study, Grand View Research has segmented the computational biology market on the basis of applications, tools, services, end users and region:

     Computational Biology Application Outlook
             Cellular & Biological Simulation
                     Computational Genomics
                     Computational Proteomics
                     Pharmacogenomics
                     Others (Transcriptomics/Metabolomics)
             Drug Discovery and Disease Modelling
                     Target Identification
                     Target Validation
                     Lead Discovery
                     Lead Optimization
             Preclinical Drug Development
                     Pharmacokinetics
                     Pharmacodynamics
             Clinical trials
                     Phase I
                     Phase II
                     Phase III
             Human Body Simulation Software
     Computational Biology Tools Outlook
             Databases
             Infrastructure (Hardware)
             Analysis Software & Services
     Computational Biology Services Outlook 
             In-house
             Contract
     Computational Biology End User Outlook 
             Academics
             Industry
             Commercial
     Computational Biology Regional Outlook
             North America
             Europe
             Asia Pacific
             RoW

 Table of Contents


Chapter 1.  Executive Summary

                1.1.  Computational Biology - Industry Summary & Critical Success Factors (CSFs)

Chapter 2.  Computational Biology Industry Outlook

                2.1.  Market Segmentation

                2.2.  Market Size and Growth Prospects

                2.3.  Computational Biology Market Dynamics

                2.4.  Key Opportunities Prioritized

                2.5.  Industry Analysis - Porter's

                2.6.  Computational Biology -Company Market Share Analysis, 2013

                2.7.  Computational Biology market PESTEL Analysis, 2013     

Chapter 3.  Computational Biology Application Outlook

                3.1.  Cellular & Biological Simulation

                    3.1.1.    Global Computational Genomics demand, (USD Million), 2012 - 2020 

                    3.1.2.    Global Computational Proteomics demand, (USD Million), 2012 - 2020

                    3.1.3.    Global Pharmacogenomics demand, (USD Million), 2012 - 2020

                    3.1.4.    Global Transcriptomics/Metabolomics demand, (USD Million), 2012 - 2020

                3.2.  Drug Discovery &Disease Modelling

                    3.2.1.    Global Target Identification market demand, (USD Million), 2012 - 2020

                    3.2.2.    Global Target Validation market demand, (USD Million), 2012 - 2020

                    3.2.3.    Global Lead Discovery market demand, (USD Million), 2012 - 2020

                    3.2.4.    Global Lead Optimization market demand, (USD Million), 2012 - 2020

                3.3.  Preclinical Drug Development

                    3.3.1.    Global Pharmacokinetics market demand, (USD Million), 2012 - 2020

                    3.3.2.    Global Pharmacodynamics market demand, (USD Million), 2012 - 2020

                3.4.  Clinical trials

                    3.4.1.    Global Phase I demand, (USD Million), 2012 - 2020

                    3.4.2.    Global Phase II demand, (USD Million), 2012 - 2020

                    3.4.3.    Global Phase III demand, (USD Million), 2012 - 2020

                3.5.  Human Body Simulation Software

                    3.5.1.    Global Human body simulation Software demand, (USD Million), 2012 - 2020

Chapter 4.  Computational Biology Tools Outlook

                4.1.  Global Databases demand, (USD Million), 2012 - 2020

                4.2.  Global Infrastructure(Hardware) demand, (USD Million), 2012 - 2020

                4.3.  Global Analysis Software & Services demand, (USD Million), 2012 - 2020

Chapter 5.  Computational Biology Services Outlook

                5.1.  Global In-house Services demand, (USD Million), 2012 - 2020

                5.2.  Global Contract Services demand, (USD Million), 2012 - 2020

Chapter 6.  Computational Biology End User Outlook

                6.1.  Global demand for Computational Biology in Academics, (USD Million), 2012 - 2020

                6.2.  Global demand for Computational Biology in Industrial Application, (USD Million), 2012 - 2020

Chapter 7.  Computational Biology Regional Outlook    

                7.1.  North America

                    7.1.1.    Computational Biology market revenue by application, (USD Million), 2012 - 2020

                    7.1.2.    Computational Biology market revenue by services, (USD Million), 2012 - 2020

                    7.1.3.    Computational Biology market revenue by tools, (USD Million), 2012 - 2020

                    7.1.4.    Computational Biology market revenue by end user, (USD Million), 2012 - 2020

                7.2.  Europe

                    7.2.1.    Computational Biology market revenue by application, (USD Million), 2012 - 2020

                    7.2.2.    Computational Biology market revenue by services, (USD Million), 2012 - 2020

                    7.2.3.    Computational Biology market revenue by tools, (USD Million), 2012 - 2020

                    7.2.4.    Computational Biology market revenue by end user, (USD Million), 2012 - 2020

                7.3.  Asia Pacific

                    7.3.1.    Computational Biology market revenue by application, (USD Million), 2012 - 2020

                    7.3.2.    Computational Biology market revenue by services, (USD Million), 2012 - 2020

                    7.3.3.    Computational Biology market revenue by tools, (USD Million), 2012 - 2020

                    7.3.4.    Computational Biology market revenue by end user, (USD Million), 2012 - 2020

                7.4.  RoW

                    7.4.1.    Computational Biology market revenue by application, (USD Million), 2012 - 2020

                    7.4.2.    Computational Biology market revenue by services, (USD Million), 2012 - 2020

                    7.4.3.    Computational Biology market revenue by tools, (USD Million), 2012 - 2020

                    7.4.4.    Computational Biology market revenue by end user, (USD Million), 2012 - 2020

Chapter 8. Computational Biology Competitive Landscape

                7.1    Accelrys

                    7.1.1    Company Overview

                    7.1.2    Financial Performance

                    7.1.3    Product Benchmarking

                    7.1.4    Strategic Initiatives

                7.2    Certara

                    7.2.1    Company Overview

                    7.2.2    Financial Performance

                    7.2.3    Product Benchmarking

                    7.2.4    Strategic Initiatives

                7.3    Chemical Computing Group Inc.

                    7.3.1    Company Overview

                    7.3.2    Financial Performance

                    7.3.3    Product Benchmarking

                    7.3.4    Strategic Initiatives

                7.4    Compugen Ltd

                    7.4.1    Company Overview

                    7.4.2    Financial Performance

                    7.4.3    Product Benchmarking

                    7.4.4    Strategic Initiatives

                7.5    Entelos

                    7.5.1    Company Overview

                    7.5.2    Financial Performance

                    7.5.3    Product Benchmarking

                    7.5.4    Strategic Initiatives

                7.6    Genedata AG

                    7.6.1    Company Overview

                    7.6.2    Financial Performance

                    7.6.3    Product Benchmarking

                    7.6.4    Strategic Initiatives

                7.7    Insilico Biotechnology AG

                    7.7.1    Company Overview

                    7.7.2    Financial Performance

                    7.7.3    Product Benchmarking

                    7.7.4    Strategic Initiatives

                7.8    Leadscope Inc

                    7.8.1    Company Overview

                    7.8.2    Financial Performance

                    7.8.3    Product Benchmarking

                    7.8.4    Strategic Initiatives

                7.9    Nimbus Discovery LLC

                    7.9.1    Company Overview

                    7.9.2    Financial Performance

                    7.9.3    Product Benchmarking

                    7.9.4    Strategic Initiatives

                7.10    Rhenovia Pharma SAS

                    7.10.1    Company Overview

                    7.10.2    Financial Performance

                    7.10.3    Product Benchmarking

                    7.10.4    Strategic Initiatives

               7.11    Schrodinger

                    7.11.1    Company Overview

                    7.11.2    Financial Performance

                    7.11.3    Product Benchmarking

                    7.11.4    Strategic Initiatives

               7.12    Simulation Plus Inc

                    7.12.1    Company Overview

                    7.12.2    Financial Performance

                    7.12.3    Product Benchmarking

                    7.12.4    Strategic Initiatives

Chapter 9. Methodology and Scope

               8.1    Research Methodology

               8.2    Research Scope & Assumptions

               8.3    List of Data Sources


List of Tables


1. Computational Biology - Industry Summary & Critical Success Factors (CSFs)
2. Global Computational Biology market,(USD Million), 2012 - 2020
3. Global Computational Biology Market by Application, (USD Million), 2012 - 2020
4. Global Cellular & Biological Simulation Market, (USD Million), 2012 - 2020
5. Global Drug Discovery & Disease Modeling Market, (USD Million), 2012 - 2020
6. Global Preclinical Drug Development Market, (USD Million), 2012 - 2020
7. Global Clinical Trials Market, (USD Million), 2012 - 2020
8. Global Human Body Simulation Software Market, (USD Million), 2012 - 2020
9. Global Computational Biology Tools Market (USD Million), 2012 - 2020
10. Global Databases Market, (USD Million), 2012 - 2020
11. Global Hardware Infrastructure Market, (USD Million), 2012 - 2020
12. Global Analysis Software and Services Market, (USD Million), 2012 - 2020
13. Global Computational Biology Services Market , (USD Million), 2012 - 2020
14. Global In-house Services Market, (USD Million), 2012 - 2020
15. Global On-contract Services Market, (USD Million), 2012 - 2020
16. Global Computational Biology Market by End Users, (USD Million), 2012 - 2020
17. Global Market for Computational Biology in Academics, (USD Million), 2012 - 2020
18. Global Market for Computational Biology Industrial Use, (USD Million), 2012 - 2020
19. Global Market for Computational Biology in Commercial Products, (USD Million), 2012 - 2020
20. Global Computational Biology by Region, (USD Million), 2012 - 2020
21. North America Computational Biology Market by Application, (USD Million), 2012 - 2020
22. North America Computational Biology Tools Market, (USD Million), 2012 - 2020
23. North America Computational Biology Services Market, (USD Million), 2012 - 2020
24. North America Computational Biology Market by End User (USD Million), 2012 - 2020
25. Europe Computational Biology Market by Application, (USD Million), 2012 - 2020
26. Europe Computational Biology Tools Market, (USD Million), 2012 - 2020
27. Europe Computational Biology Services Market, (USD Million), 2012 - 2020
28. Europe Computational Biology Market by End User (USD Million), 2012 - 2020
29. Asia Pacific Computational Biology Market by Application, (USD Million), 2012 - 2020
30. Asia Pacific Computational Biology Tools Market, (USD Million), 2012 - 2020
31. Asia Pacific Computational Biology Services Market, (USD Million), 2012 - 2020
32. Asia Pacific Computational Biology Market by End User (USD Million), 2012 - 2020
33. RoW Computational Biology Market by Application, (USD Million), 2012 - 2020
34. Row Computational Biology Tools Market, (USD Million), 2012 - 2020
35. Row Computational Biology Services Market, (USD Million), 2012 - 2020
36. RoW Computational Biology Market by End User (USD Million), 2012 - 2020


List of Figures

1. Computational Biology Market Segmentation
2. Global Computational Biology Market Revenue, 2012 - 2020
3. Computational Biology Value Chain Analysis
4. Computational Biology Market Dynamics
5. Computational Biology - Company market Share Analysis, 2013
6. Key Opportunities Prioritized
7. Industry Analysis - Porter's
8. Computational Biology PESTEL Analysis, 2013
9. Computational Biology Market by Application, 2013& 2020
10. Global Computational Biology Market by Application, (USD Million), 2012 - 2020
11. Global Cellular & Biological Simulation Market, (USD Million), 2012 - 2020
12. Global Computational Genomics demand, (USD Million), 2012 - 2020
13. Global Computational Proteomics demand, (USD Million), 2012 - 2020
14. Global Pharmacogenomics demand, (USD Million), 2012 - 2020
15. Global Transcriptomics/Metabolomics demand, (USD Million), 2012 - 2020
16. Global Drug Discovery & Disease Modeling Market, (USD Million), 2012 - 2020
17. Global Target Identification demand, (USD Million), 2012 - 2020
18. Global Target Validation demand, (USD Million), 2012 - 2020
19. Global Lead Discovery demand, (USD Million), 2012 - 2020
20. Global Lead Optimization demand, (USD Million), 2012 - 2020
21. Global Preclinical Drug Development Market, (USD Million), 2012 - 2020
22. Global Pharmacokinetics demand, (USD Million), 2012 - 2020
23. Global Pharmacodynamics demand, (USD Million), 2012 - 2020
24. Global Clinical Trials Market, (USD Million), 2012 - 2020
25. Global Phase I Clinical Trials demand, (USD Million), 2012 - 2020
26. Global Phase II Clinical Trials demand, (USD Million), 2012 - 2020
27. Global Phase III Clinical Trials demand, (USD Million), 2012 - 2020
28. Global Human Body Simulation Software Market, (USD Million), 2012 - 2020
29. Computational Biology Tools Market (USD Million), 2013 &2020
30. Global Databases Market, (USD Million), 2012 - 2020
31. Global Hardware Infrastructure Market, (USD Million), 2012 - 2020
32. Global Analysis Software and Services Market, (USD Million), 2012 - 2020
33. Computational Biology Services Market , (USD Million), 2013 &2020
34. Global In-house Services Market, (USD Million), 2012 - 2020
35. Global On-contract Services Market, (USD Million), 2012 - 2020
36. Computational Biology Market by End Users, (USD Million), 2013& 2020
37. Global Market for Computational Biology in Academics, (USD Million), 2012 - 2020
38. Global Market for Computational Biology Industrial Use, (USD Million), 2012 - 2020
39. Global Market for Commercial Use of Computational Biology, (USD Million), 2012 - 2020
40. Computational Biology Market by Region, 2013& 2020
41. North America Computational Biology Market, (USD Million), 2012 - 2020
42. Europe Computational Biology Market, (USD Million), 2012 - 2020
43. Asia Pacific Computational Biology Market, (USD Million), 2012 - 2020
44. RoW Computational Biology Market, (USD Million), 2012 - 2020